期刊文献+

多因素回归分析全关节置换术后华法林使用效果

Multifactor regression analysis of the effect of using warfarin following total joint replacement
下载PDF
导出
摘要 目的探讨华法林使用剂量和患者因素对全关节置换术后效果的影响。方法选取250例行全关节置换术患者,手术前后给予华法林治疗以预防静脉血栓形成。多因素回归模型分析患者的情况和华法林使用的情况以及华法林使用的影响因素。结果多因素回归分析结果显示,患者的年龄、体重、华法林每日剂量、最大剂量、累积剂量以及住院时间均显著影响华法林的使用效果;每日剂量多因素回归分析结果显示,华法林每日剂量以及住院时间显著影响使用效果;累积剂量多因素回归模型分析结果显示,华法林最大剂量以及住院时间显著影响华法林使用效果。结论患者的年龄、体重以及华法林每日剂量、最大剂量、住院时间均显著影响华法林的使用效果。 Objective To investigate the influence of warfarin using dose and patient factors on postoperative effect following the total joint replacement.Methods The 250 patients who underwent total joint replacement were treated with warfarin before and after the operation to prevent venous thrombosis,multifactor regression analysis model was used to analyze the general situation and the use situation of warfarin in all patients and the effect factors of warfarin.Results Multivariate regression analysis showed that age,body weight,daily warfarin dose,maximum dose,cumulative dose and hospitalization time significantly affected warfarin use effects;multifactor regression analysis of average daily dose showed that daily use dose of warfarin and hospitalization time significantly affected warfarin use effect;multivariate regression model analysis of cumulative dose showed that maximum warfarin dose and hospitalization time significantly affected warfarin use.Conclusions The patients′age,body weight and daily warfarin dose,the maximum dose,hospitalization time all significantly affect warfarin use.
作者 邓亚军 姜棚菲 张杰 张民泽 DENG Ya-jun;JIANG Peng-fei;ZHANG Jie;ZHANG Min-ze(SectionⅣ,Dept of Orthopaedics,the Affiliated Hospital of Yan′an University,Yan′an,Shaanxi716000,China)
出处 《临床骨科杂志》 2018年第2期178-181,共4页 Journal of Clinical Orthopaedics
关键词 全关节置换术 静脉血栓 华法林 国际标准化比率 total joint replacement venous thrombosis warfarin international normalized ratio(INR)
  • 相关文献

参考文献1

二级参考文献8

  • 1郑露,魏迎凤,徐学康.小剂量华法令预防尿毒症长期留置导管栓塞的疗效观察[J].中国中西医结合肾病杂志,2007,8(3):130-130. 被引量:5
  • 2Hirsh J, Fuster V,Ansell J.American Heart Association/AmericanCollege of Cardiology Foundation guide to warfarin therapy[J].Circulation, 2003, 107(12): 1692-1711.
  • 3Coli L, Donati G, Gianciolo G, et al.Anticoagulation therapyfor the prevention of hemodialysis tunneled cuffed catheters(TCC)thrombosis[J].J Vase Access, 2006, 7(3): 118-122.
  • 4Wilkieson T J, Ingram A J, Crowther M A, et al丄ow-intensityadjusted-dose warfarin for the prevention of hemodialysis catheterfailure: a randomized, controlled trial[J].Clin J Am Soc Nephrol,2011,6(5): 1018-1024.
  • 5Minako Wakasugi, Junichiro James Kazama, Akihide Tokumoto,et al.Association between warfarin use and incidence of ischemicstroke in Japanese hemodialysis patients with chronic sustained atrialfibrillation : a prospective cohort study[J].Clinical and ExperimentalNephrology, 2014, 18(4): 662-669.
  • 6Elliott M J, Zimmerman D, Holden R M.Warfarin Anticoagulationin Hemodialysis Patients : A Systematic Review of Bleeding Rates[J].American Journal of Kidney Diseases,2007,50(3) : 433-440.
  • 7李剑文,刘日光,傅君舟.抗血小板药在治疗长期留置血液透析导管晚期功能不良中的应用[J].临床和实验医学杂志,2009,8(9):20-22. 被引量:12
  • 8范雪飞.维护流程改造对血液透析留置导管的临床应用分析[J].中外医学研究,2014,12(9):136-137. 被引量:3

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部